Literature DB >> 27885382

MRI in flexor tendon rupture after collagenase injection.

Shruti Khurana1, Vibhor Wadhwa2, Avneesh Chhabra3,4, Bardia Amirlak3.   

Abstract

Flexor tendon rupture is an unusual complication following collagenase injection to relieve contractures. These patients require a close follow-up and in the event of tendon rupture, a decision has to be made whether to repair the tendon or manage the complication conservatively. The authors report the utility of MRI in the prognostication and management of a patient with Dupuytren's contracture, who underwent collagenase injection and subsequently developed flexor digitorum profundus tendon rupture.

Entities:  

Keywords:  Collagenase; Dupuytren’s contracture; Flexor digitorum profundus; Magnetic resonance imaging

Mesh：

Substances：

Year:  2016        PMID： 27885382     DOI： 10.1007/s00256-016-2524-2

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN： 0364-2348            Impact factor:   2.199


  17 in total

Review 1.  Advances in the understanding of the aetiology of Dupuytren's disease.

Authors:  Natasha E Picardo; Wasim S Khan
Journal:  Surgeon       Date:  2012-01-30       Impact factor: 2.392

2.  Results of partial fasciectomy for Dupuytren disease in 261 consecutive patients.

Authors:  J Henk Coert; Juan P Barret Nérin; Marcel F Meek
Journal:  Ann Plast Surg       Date:  2006-07       Impact factor: 1.539

3.  Flexor tendon rupture after collagenase injection for Dupuytren contracture: case report.

Authors:  Andrew Y Zhang; Catherine M Curtin; Vincent R Hentz
Journal:  J Hand Surg Am       Date:  2011-06-25       Impact factor: 2.230

4.  Sonographically guided tendon sheath injections are more accurate than blind injections: implications for trigger finger treatment.

Authors:  Dae-Hee Lee; Seung-Beom Han; Jong-Woong Park; Soon-Hyuck Lee; Kwan-Woo Kim; Woong-Kyo Jeong
Journal:  J Ultrasound Med       Date:  2011-02       Impact factor: 2.153

5.  Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contractures.

Authors:  Stephen Coleman; David Gilpin; F Thomas D Kaplan; Anthony Houston; Gregory J Kaufman; Brian M Cohen; Nigel Jones; James P Tursi
Journal:  J Hand Surg Am       Date:  2013-12-04       Impact factor: 2.230

6.  Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease.

Authors:  David Gilpin; Stephen Coleman; Stephen Hall; Anthony Houston; Jeff Karrasch; Nigel Jones
Journal:  J Hand Surg Am       Date:  2010-12       Impact factor: 2.230

7.  Acute double flexor tendon ruptures following injection of collagenase clostridium histolyticum (Xiapex) for Dupuytren's contracture.

Authors:  Bo Povlsen; Sarvpreet Singh
Journal:  BMJ Case Rep       Date:  2014-04-12

8.  In vitro study of novel collagenase (XIAFLEX®) on Dupuytren's disease fibroblasts displays unique drug related properties.

Authors:  Farhatullah Syed; Alexis N Thomas; Subir Singh; Venkatesh Kolluru; Susan G Emeigh Hart; Ardeshir Bayat
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

9.  Isolated and spontaneous correction of proximal interphalangeal joint contractures in Dupuytren's disease: an exploratory analysis of the efficacy and safety of collagenase Clostridium histolyticum.

Authors:  Michael J Hayton; Ardeshir Bayat; Douglass S Chapman; Robert A Gerber; Piotr P Szczypa
Journal:  Clin Drug Investig       Date:  2013-12       Impact factor: 2.859

Review 10.  Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren's contracture.

Authors:  C A Peimer; S Wilbrand; R A Gerber; D Chapman; P P Szczypa
Journal:  J Hand Surg Eur Vol       Date:  2014-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.